S. Shariat

BLADDER CANCER: ESMO CLINICAL PRACTICE GUIDELINE FOR DIAGNOSIS, TREATMENT AND FOLLOW-UP†.

A. Ravaud, R. Huddart, T. Powles, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?

P. Colin, M. Rouprêt, T. Seisen, 2016, Translational andrology and urology.

The efficacy of BCG Tice and BCG Connaught in a cohort of 2099 T1G3 non-muscle invasive bladder cancer patients

N. Malats, M. Babjuk, R. Sylvester, 2017 .

Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy population.

T. Helbich, P. Clauser, P. Baltzer, 2022, European journal of radiology.

Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.

C. Stief, S. Pahernik, M. Hohenfellner, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: A systematic review and network meta-analysis of oncologic and toxicity outcomes

K. Mori, D. Enikeev, I. Resch, 2022, European Urology.

International opinions on grading of urothelial carcinoma: A survey among European Association of Urology and International Society of Urological Pathology members

A. Masson-Lecomte, M. Babjuk, R. Sylvester, 2023, European Urology.

Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors.

P. Weibl, H. Klingler, M. Remzi, 2014, European journal of radiology.